Society for Menstrual Cycle Research
December 13th, 2009 by Elizabeth Kissling
There’s a pretty good essay in this weekend’s New York Times (online here Saturday, in print Sunday in the Business section) about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. In addition to discussion of Wyeth’s advertising campaigns, the article mentions the firm’s contract with DesignWrite, a company drug makers pay to develop manuscripts for publication in medical journals, to prepare at least 60 articles for publication in medical journals on the potential benefits of hormone therapy for cardiovascular disease, Alzheimer’s disease, diabetes, colon cancer, vision loss and other health problems.
Comment from Leslie
Excellent diagram at the bottom of the page – with some insights into what goes on behind the scenes at the marketing meetings. Am thinking that the same terms are used in marketing meetings regarding the HPV vaccine. Dismiss and distract – with little girls dancing around the room singing “one less” – while they become “one more” victim of a vaccine gone bad.
If you liked my post, feel free to subscribe to my rss feeds
BlogoSquare